387 related articles for article (PubMed ID: 33669290)
1. Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases.
Ghebretatios M; Schaly S; Prakash S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669290
[TBL] [Abstract][Full Text] [Related]
2. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health.
Lamas B; Martins Breyner N; Houdeau E
Part Fibre Toxicol; 2020 Jun; 17(1):19. PubMed ID: 32487227
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Alimentary Tract Injury.
Chen Y; Wu G; Zhao Y
Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota.
Fröhlich EE; Fröhlich E
Int J Mol Sci; 2016 Apr; 17(4):509. PubMed ID: 27058534
[TBL] [Abstract][Full Text] [Related]
5. Progress in the characterization and safety evaluation of engineered inorganic nanomaterials in food.
Wang H; Du LJ; Song ZM; Chen XX
Nanomedicine (Lond); 2013 Dec; 8(12):2007-25. PubMed ID: 24279490
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterials and neurodegeneration.
Migliore L; Uboldi C; Di Bucchianico S; Coppedè F
Environ Mol Mutagen; 2015 Mar; 56(2):149-70. PubMed ID: 25627719
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota, dysbiosis and colon lavage.
Drago L; Valentina C; Fabio P
Dig Liver Dis; 2019 Sep; 51(9):1209-1213. PubMed ID: 31358483
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral exposure to titanium dioxide nanoparticles on gut microbiota and gut-associated metabolism in vivo.
Chen Z; Han S; Zhou D; Zhou S; Jia G
Nanoscale; 2019 Nov; 11(46):22398-22412. PubMed ID: 31738363
[TBL] [Abstract][Full Text] [Related]
9. Intra-amniotic administration (Gallus gallus) of TiO
Kolba N; Guo Z; Olivas FM; Mahler GJ; Tako E
Food Chem Toxicol; 2020 Jan; 135():110896. PubMed ID: 31654707
[TBL] [Abstract][Full Text] [Related]
10. Foodborne Titanium Dioxide Nanoparticles Induce Stronger Adverse Effects in Obese Mice than Non-Obese Mice: Gut Microbiota Dysbiosis, Colonic Inflammation, and Proteome Alterations.
Cao X; Han Y; Gu M; Du H; Song M; Zhu X; Ma G; Pan C; Wang W; Zhao E; Goulette T; Yuan B; Zhang G; Xiao H
Small; 2020 Sep; 16(36):e2001858. PubMed ID: 32519440
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiome and irritable bowel syndrome: State of art review.
Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
[TBL] [Abstract][Full Text] [Related]
12. Dietary nanoparticles alter the composition and function of the gut microbiota in mice at dose levels relevant for human exposure.
Perez L; Scarcello E; Ibouraadaten S; Yakoub Y; Leinardi R; Ambroise J; Bearzatto B; Gala JL; Paquot A; Muccioli GG; Bouzin C; van den Brule S; Lison D
Food Chem Toxicol; 2021 Aug; 154():112352. PubMed ID: 34153347
[TBL] [Abstract][Full Text] [Related]
13. Impact of nanosilver on gut microbiota: a vulnerable link.
Dahiya DK; Renuka ; Puniya AK
Future Microbiol; 2018 Mar; 13():483-492. PubMed ID: 29264949
[TBL] [Abstract][Full Text] [Related]
14. Digestive disorders and Intestinal microbiota.
Nouvenne A; Ticinesi A; Tana C; Prati B; Catania P; Miraglia C; De' Angelis GL; Di Mario F; Meschi T
Acta Biomed; 2018 Dec; 89(9-S):47-51. PubMed ID: 30561395
[TBL] [Abstract][Full Text] [Related]
15. Effects of microplastic and engineered nanomaterials on inflammatory bowel disease: A review.
Zhao Y; Liu S; Xu H
Chemosphere; 2023 Jun; 326():138486. PubMed ID: 36963581
[TBL] [Abstract][Full Text] [Related]
16. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
[TBL] [Abstract][Full Text] [Related]
18. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
19. Factors Conditioning the Potential Effects TiO2 NPs Exposure on Human Microbiota: a Mini-Review.
Baranowska-Wójcik E
Biol Trace Elem Res; 2021 Dec; 199(12):4458-4465. PubMed ID: 33447907
[TBL] [Abstract][Full Text] [Related]
20. Can Probiotics Cure Inflammatory Bowel Diseases?
Korada SK; Yarla NS; Bishayee A; Aliev G; Aruna Lakshmi K; Arunasree MK; Dananajaya BL; Mishra V
Curr Pharm Des; 2016; 22(7):904-17. PubMed ID: 26648465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
